Match!
Mohammad Y. Zaidi
Emory University
SurgeryPathologyNeuroendocrine tumorsGeneral surgeryMedicine
42Publications
4H-index
111Citations
What is this?
Publications 47
Newest
#1Eliza W. Beal (The Ohio State University Wexner Medical Center)H-Index: 10
#2Ahmed Ahmed (The Ohio State University Wexner Medical Center)H-Index: 1
Last. Jordan M. Cloyd (The Ohio State University Wexner Medical Center)H-Index: 9
view all 27 authors...
Abstract Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an increasingly utilized strategy for patients with peritoneal surface malignancies (PSM). Methods The US HIPEC Collaborative was retrospectively reviewed to compare the indications and perioperative outcomes of patients who underwent CRS ± HIPEC between 2000 and 2012 (P1) versus 2013–2017 (P2). Results Among 2,364 patients, 39% were from P1 and 61% from P2. The most common primary site was ...
Source
#1Jason T. Wiseman (OSU: Ohio State University)H-Index: 8
#1Jason T. Wiseman (OSU: Ohio State University)H-Index: 1
Last. Jordan M. Cloyd (OSU: Ohio State University)H-Index: 9
view all 27 authors...
Background Anastomotic failure (AF) after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) remains a dreaded complication. Whether specific factors, including anastomotic technique, are associated with AF is poorly understood.
1 CitationsSource
#1Rachel M. Lee (Emory University)H-Index: 1
#2Mohammad Y. Zaidi (Emory University)H-Index: 4
Last. Maria C. Russell (Emory University)H-Index: 16
view all 28 authors...
Abstract Background Radiographic prediction of PCI can improve patient selection for cytoreductive surgery. We aimed to determine the correlation of CT-predicted PCI (CT-PCI) and MRI-predicted PCI (MRI-PCI) with intraoperative-PCI, and if a preoperative-PCI cutoff is associated with incomplete cytoreduction. Patients and Methods Patients from the US HIPEC Collaborative (2000-17) with appendiceal, colorectal, or peritoneal mesothelioma (PM) histology who underwent cytoreductive surgery were inclu...
Source
#1Michael B. Ware (Emory University)H-Index: 1
#2Christopher McQuinn (OSU: Ohio State University)H-Index: 3
Last. Jacob S. Bowers (MUSC: Medical University of South Carolina)H-Index: 8
view all 17 authors...
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is exceptionally resistant to immune checkpoint inhibition (ICI). We previously reported that elevated systemic interleukin-6 (IL-6) and increased numbers of T cells positive for circulating cytotoxic T-lymphocyte-associated protein 4 (CTLA 4) correlate with worse overall survival in patients with PDAC. We postulated that combined blockade of IL-6 and CTLA-4 would significantly enhance anti-tumor immune responses to PDAC. Dual blockade of IL-6 an...
Source
#1Michael K. Turgeon (Emory University)
#2Adriana C. Gamboa (Emory University)H-Index: 1
Last. Callisia N. Clarke (MCW: Medical College of Wisconsin)H-Index: 11
view all 20 authors...
184Background: Patient age is often a significant factor in preoperative selection for major abdominal surgery. Its association with postoperative outcomes in patients undergoing cytoreductive surg...
Source
#1Matthew R. FarrenH-Index: 5
Last. Gregory B. LesinskiH-Index: 29
view all 15 authors...
Source
#1Tiffany C. Lee (UC: University of Cincinnati)H-Index: 1
#2Koffi Wima (UC: University of Cincinnati)H-Index: 14
Last. Sameer H. Patel (UC: University of Cincinnati)H-Index: 14
view all 27 authors...
Source
#1Nick C. Levinsky (University of Cincinnati Academic Health Center)H-Index: 3
#2Mackenzie C. Morris (University of Cincinnati Academic Health Center)H-Index: 1
Last. Sameer H. Patel (University of Cincinnati Academic Health Center)H-Index: 14
view all 28 authors...
Background Appendiceal adenocarcinoma with signet ring cells (SCA) is associated with worse overall survival (OS), and it is unclear whether cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) should be pursued in this patient population. We assessed the prognostic implications of signet ring cells in patients with appendiceal adenocarcinoma and peritoneal carcinomatosis undergoing CRS-HIPEC.
Source
#1Adriana C. Gamboa (Emory University)H-Index: 1
#2Mohammad Y. Zaidi (Emory University)H-Index: 4
Last. Shishir K. Maithel (Emory University)H-Index: 38
view all 31 authors...
Background No guidelines exist for surveillance following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal and colorectal cancer. The primary objective was to define the optimal surveillance frequency after CRS/HIPEC.
1 CitationsSource
#1Mohammad Y. Zaidi (Emory University)H-Index: 4
#2Rachel M. Lee (Emory University)H-Index: 1
Last. Charles A. Staley (Emory University)H-Index: 39
view all 29 authors...
Background For patients with peritoneal carcinomatosis undergoing cytoreductive surgery with heated intraperitoneal chemotherapy (CRS/HIPEC), incomplete cytoreduction (CCR2/3) confers morbidity without survival benefit. The aim of this study is to identify preoperative factors which predict CCR2/3.
1 CitationsSource
12345